8-K - Emmaus Life Sciences, Inc. | StockGist

Current Report Details

Event Type

Material Agreement+3 More

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

Entry into a Material Definitive Agreement On December 17, 2025, Emmaus Life Sciences, Inc. (“we,” “us,” “our,” “Emmaus” and the “company”) entered into an Exch

Material Agreement

$600.0K$3.0M

Source Document

2.03

Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant The information in Item 1.01 of this Report wi

Financing

3.02

Unregistered Sale of Securities The information in Item 1.01 of this Report regarding the issuance of the Exchange Securities is hereby incorporated herein by r

Securities Issuance

9.01

Financial Statements and Exhibits (d) Exhibits See the accompanying Index to Exhibits, which information is incorporated herein by reference. 1 SIGNATURES Pursu

Exhibits Only

Exhibits (3)

10.1

EXCHANGE AGREEMENT DATED AS OF DECEMBER 17, 2025

4.1

CONVERTIBLE PROMISSORY NOTE ISSUED DECEMBER 17. 2025

8-K

CURRENT REPORT